Human marrow transplantation: an immunological perspective (Q39462944)

12 September 2017

1 reference

title

Human marrow transplantation: an immunological perspective (English)

1 reference

12 September 2017

1 reference

3

R Storb

1 reference

12 September 2017

4

E D Thomas

1 reference

12 September 2017

P J Martin

1

1 reference

12 September 2017

J A Hansen

series ordinal

2

1 reference

12 September 2017

publication date

1 January 1987

1 reference

12 September 2017

published in

Advances in Immunology

1 reference

12 September 2017

volume

40

1 reference

12 September 2017

page(s)

379-438

1 reference

Supralethal whole body irradiation and isologous marrow transplantation in man.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The major histocompatibility complex--genetics and biology (second of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Prophylactic granulocyte transfusions during human bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Protective environment for marrow transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Allogeneic Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation from donors other than HLA identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Transplantation of marrow from an unrelated donor to a patient with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The use of partially matched, unrelated donors in clinical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Indications for Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Total body irradiation in bone marrow transplantation: the influence of fractionation and delay of marrow infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone Marrow Transplantation with Intensive Combination Chemotherapy/Radiation Therapy (SCARI) in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

ABO-incompatible bone marrow transplantation: preparation by plasma exchange and in vivo antibody absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Immunoadsorption for removal of A and B blood-group antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Hematopoietic stem cells (second of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone marrow transplantation from donors with aplastic anemia. A report from the ACS/NIH bone marrow transplant registry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone marrow graft rejection as a function of antibody-directed natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Marrow grafts between phenotypically DLA-identical and haploidentical unrelated dogs: additional antigens controlling engraftment are not detected by cell-mediated lympholysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Lasting engraftment of histoincompatible bone marrow cells in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Influence of Thymus Cells on Erythropoiesis of Parental Marrow in Irradiated Hybrid Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

INDEPENDENCE OF DEFICIENT EARLY GROWTH AND LATER REGRESSION OF (C57BL X 101)F2 MARROW GRAFTS IN (C57BL X 101)F1 HYBRID MICE

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

F1 hybrid resistance: long-term systemic effects sensitive to irradiation and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Suppression of cell-mediated lymphocytotoxicity against minor histocompatibility antigens mediated by Lyt-1+Lyt−2+ T cells of stimulator-strain origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Aberrations of suppressor T cells in human graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft-versus-host disease in recipients of syngeneic bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Acute "graft-versus-host disease" after autografting for chronic granulocytic leukemia in transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Histological and ultrastructural appearance of the liver during graft-versus-host disease complicating bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Histopathological changes in the liver after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The fine structure of human rectal epithelium in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Lethal GVHD Across Minor Histocompatibility Barriers: Nature of the Effector Cells and Role of the H-2 Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Absence of correlation between cytolytic T lymphocytes and lethal murine graft-versus-host disease in response to minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Hypersensitivity reactions in the small intestine. 6. Pathogenesis of the graft-versus-host reaction in the small intestinal mucosa of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Pathological changes in inbred strains of mice following early thymectomy and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Role of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The induction of graft versus host disease in mice treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Dissociation of splenomegaly from graft-versus-host disease by host x-irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The effect of cytotoxic drugs on graft-versus-host disease in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Increased graft-versus-host response of parental-strain (donor) lymphoid cells in cyclophosphamide-treated F1 recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Association between HLA-B antigens and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

A possible predictive test for graft-versus-host disease in bone marrow graft recipients: the mixed-epidermal cell-lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Response of graft versus host disease to high doses of methyl prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Cyclosporin A for the treatment of graft-versus-host disease in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

The effects of cyclosporin A on the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Chronic graft versus host disease: a syndrome of disordered immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Cutaneous manifestations of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Sjögren-Type Syndrome After Allogeneic Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft-versus-host reaction. Cutaneous manifestations following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Scleroderma, Sjögren-like Syndrome, and Chronic Graft-Versus-Host Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Scleroderma-like graft-versus-host disease as late consequence of bone-marrow grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Oral manifestations of chronic graft-v-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Ocular Manifestations of Graft-v-Host Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Radiographic features of esophageal involvement in chronic graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Chronic graft-versus-host disease in the rat radiation chimera. II. Immunological evaluation in long-term chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

T cell growth factor abrogates concanavalin A-induced suppressor cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Immunoglobulin synthesis following allogeneic bone marrow transplantation in man. Conversion to donor allotype

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Direct evidence for a bone marrow origin of the alveolar macrophage in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Bone Marrow Origin of Hepatic Macrophages (Kupffer Cells) in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Chromosomal Evidence of Donor B-Lymphocyte Engraftment after Bone-Marrow Transplantation in a Patient with Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Studies of immunological reactivity following syngeneic or allogeneic marrow grafts in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Immunocompetence following allogeneic bone marrow transplantation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Pattern of T cell reconstitution following allogeneic bone marrow transplantation for acute hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

T cell regeneration after allogeneic and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Phenotype of recovering lymphoid cell populations after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Failure of T and B cell cooperation during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Regulation of immunoglobulin production after human marrow grafting. The role of helper and suppressor T cells in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Association between pre-transplant natural kill and graft-versus-host disease after stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Natural immunity and graft-vs-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Alveolar macrophage dysfunction in human bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Defective neutrophil chemotaxis in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Neutrophil Function in Bone Marrow Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Recurrent Infection with Herpes Simplex Virus after Marrow Transplantation: Role of the Specific Immune Response and Acyclovir Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Effect of Indomethacin on the in Vitro Lymphocyte Transformation Response to Herpes Simplex Virus Antigen and Phytohemagglutinin after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Immunoblastic Sarcoma in Donor Cells after Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Treatment of murine leukaemia with x-rays and homologous bone marrow. II

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Graft-versus-leukemia effect following allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960243-6

7 January 2021

Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0065-2776(08)60243-6

Impaired growth of a radiation-induced lymphoma in intact or lethally irradiated allogeneic athymic (nude) mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0065-2776(08)60243-6

Identifiers

DOI

10.1016/S0065-2776(08)60243-6

0 references

1 reference